HIV

Researchers examine how socialization institutes effect the way individuals in low income areas relate to HIV/AIDS after a natural disaster.

Novel prevention methods can help reduce the 45,000 new cases of HIV that occur in the United States annually.

Antiretroviral therapy use and viral suppression heavily impacted by issues such as poverty and race.

While cancer spending contributes largely to medical spending, it only accounted for 6.3% of growth from 2000 to 2012.

Some injection drug users with HIV and hepatitis C seem to have the same immune problems as the elderly.

Protease inhibitors can frequently lead to cardiovascular disease, diabetes, and obesity.

As public health authorities seek to raise awareness about HIV testing, a study funded by the National Association of Chain Drug Stores Foundation is evaluating a model which may provide patients with increased access to HIV and Hepatitis C testing, and link patients to a specialized physician or health department as needed for further care.

Engineering bacteria to deliver HIV-1 neutralizing antibodies at the site where the virus enters the body may offer a cost-effective barrier to HIV-1 transmission.

Ryan White HIV/AIDS Program offers medical care and services for low income, uninsured, and underinsured individuals.

Healthy T cells from a donor were able to recognize cancer cells that patients’ T cells were not able to.

HIV-positive patients have a higher risk of cardiovascular disease, along with higher rates of hypertension.

Top news of the day from across the healthcare landscape.

HIV-positive patients experience 4 times more chronic kidney disease cases than HIV-negative patients.

HIV-positive patients carry a heavy burden.

Pharmacists can manage HIV comorbid conditions, produce cost savings, reduce drug interactions, and expedite viral load suppression.

HIV-like virus eliminated from body with early administration of treatment.

With the advent of highly active antiretroviral therapy, HIV-infected patients are more likely to die of causes other than AIDS.

Linda Spooner, PharmD, RPh, BCPS, FASHP, professor of pharmacy practice at MCPHS University, discusses ways health-system pharmacists can assist HIV patients who have just been admitted.

Further research is needed for HIV to be treated by the CRISPR/Cas9 gene editing tool.

Protease inhibitors can lead to the development of cardiovascular disease, diabetes, and obesity in patients with HIV.

Pod-intravaginal rings offered complete protection from new SHIV infections in macaques.

Certain cancer cells evade the immune system through blocking NLRC5.

Several public health interventions could prevent HIV transmission among injection drug users.

Interdisciplinary teams are commonplace in HIV care, but the inclusion of a pharmacist on these care teams is relatively rare compared with other disease states.

Harnessing the immune system may lead to an effective HIV vaccine strategy.